Pharma news: PhRMA: 258 Vaccines in Clinical Development Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present


Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, August 20, 2016

Pharma news: PhRMA: 258 Vaccines in Clinical Development


 19 August 2016. An industry group of American pharmaceutical makers says its companies have 258 vaccines, including immunotherapies, in clinical trials or awaiting FDA approval. The report, issued today by Pharmaceutical Research and Manufacturers of America, or PhRMA, covers preventive vaccines against infectious disorders, as well as disease treatments that harness the body’s immune system....

partial ovarian cancer/solid tumors -  (click on 'report' for full list)

 AE-O vaccine
Antigen Express
ovarian cancer
Phase I
(peptide vaccine)
Wellesley, MA

BriaCell Therapeutics
ovarian cancer
Phase I
SV-BR 1 GM cancer vaccine
Berkeley, CA

cancer immunotherapy
AiVita Biomedical
ovarian cancer
Phase II
(ovarian cancer stem cell therapy)
Irvine, CA

gynecological cancers
Phase I/II

CMB 305
solid cancers expressing NY-ESO-1
Phase I


Post a Comment

Your comments?